Structure-based design, synthesis, and pharmacologic evaluation tf peptide RGS4 inhibitors

Journal of Peptide Research

Volumn 63, Issue 2, 2004, Pages 141-146

  Jin, Y ^a   Zhong, H ^b   Omnaas, J R ^a   Neubig, R R ^a,b   Mosberg, H I ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cyclic peptides; G proteins; GTPase activating proteins; Protein protein interactions; Regulator of G protein signaling

Indexed keywords

CYCLOPEPTIDE; ISOPROTEIN; PEPTIDE DERIVATIVE; PROTEIN INHIBITOR; RGS PROTEIN;

ARTICLE; CRYSTAL STRUCTURE; EVALUATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; GTPASE-ACTIVATING PROTEINS; INHIBITORY CONCENTRATION 50; PEPTIDES, CYCLIC; RGS PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1542406598     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.2003.00114.x     Document Type: Article

References (14)

1. Druey, K.M., Blumer, K.J., Kang, V.H. & Kehrl, J.H. (1996) Inhibition of G-protein mediated MAP kinase activation by a new mammalian gene family. Nature 379, 742-746.
2. Koelle, M.R. & Horvitz, H.R. (1996) EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 84, 115-125.
3. Siderovski, D.P., Strockbine, B. & Behe, C.I. (1999) Whither goest the RGS proteins? Crit. Rev. Biochem. Mol. Biol. 34, 215-251.
4. Hepler, J.R. (1999) Emerging roles for RGS proteins in cell signaling. Trends Pharmacol. Sci. 10, 376-382.
5. De Vries, L., Zheng, B., Fischer, T., Elenko, E. & Farquhar, M.G. (2000) The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40, 235-271.
6. Zhong, H.L. & Neubig, R.R. (2001) RGS proteins: novel multifunctional drug targets. J. Pharmacol. Expl. Ther. 197, 837-845.
7. Neubig, R.R. & Siderovski, D.P. (2002) Regulators of G-protein signaling as new central nervous system drug targets. Nat. Rev. Drug Discov. 1, 189-199.
8. 4-activated G(i alpha 1): stabilization of the transition state for GTP hydrolysis. Cell 89, 251-261.
9. Lambright, D.G., Noel, J.P., Hamm, H.E. & Sigler, P.B. (1994) Structural determinants for activation of the alpha-subunit of a heterotrimeric G-protein. Nature 369, 621-628.
10. Macdonald, R.L. & Olsen, R.W. (1994) GABA (A) receptor channels. Annu. Rev. Neurosci. 17, 569-602.
11. Wade, S.M., Lim, W., Lan, K.L., Chung, D.A., Nanamori, M. & Neubig, R.R. (1999) Gi activator region of 2A-adrenergic receptors: distinct basic residues mediate Gi versus Gs activation. Mol. Pharmacol. 56, 1005-1013.
12. 7. J. Biol. Chem. 175, 33497-33503.
13. Zhong, H., Wade, S.M., Woolf, P.J., Linderman, J.J., Traynor, T.R. & Neubig, R.R. (2003) A spatial focusing model for G protein signals: regulator of G protein signaling (RGS) protein-mediated kinetic scaffolding. J. Biol. Chem. 178, 7278-7284.
14. Lan, K.-L., Sarvazyan, N.A., Taussig, R., Mackenzie, R.G., DiBello, P.R., Dohlman, H.G. & Neubig, R.R. (1998) A point mutation in Go and Gi1 blocks interaction with regulator of G protein signaling proteins. J. Biol. Chem. 273, 12794-12797.